New Drug for Alzheimer Disease Shows Promise in Phase 3 Trial

Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer - associated amyloid plaques in the brain
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Neurology, Pharmacy, Psychiatry, Institutional, Source Type: news